id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-P-0194-0003,FDA,FDA-2001-P-0194,FDA,Notice,NFR-Notice of Final Rule,2002-09-18T04:00:00Z,2002,9,,,2008-04-25T02:38:06Z,,0,0,09000064804e2c6c
FDA-2001-P-0194-0002,FDA,FDA-2001-P-0194,FDA,Notice,NPR-Notice of Proposed Rule-Making,2002-03-01T05:00:00Z,2002,3,2002-03-01T05:00:00Z,2002-04-23T03:59:59Z,2008-04-25T02:38:05Z,,0,0,09000064804e2c68
FDA-2001-P-0194-0001,FDA,FDA-2001-P-0194,FDA/DDM to Dade Behring Inc.,Other,ACK-Acknowledgement Letter,2001-03-06T05:00:00Z,2001,3,,,2008-04-25T02:38:06Z,,0,0,09000064804e2bef